ストックスクリーナーアプリを入手
1.65
0.61%
0.01
前日終値:
$1.64
開ける：
$1.65
24時間の取引高:
119.83K
Relative Volume:
1.70
時価総額：
$57.48M
収益：
-
当期純損益:
$-14.47M
株価収益率:
-1.3306
EPS:
-1.24
ネットキャッシュフロー:
$-12.19M
1週間 パフォーマンス:
-2.94%
1か月 パフォーマンス:
-10.33%
6か月 パフォーマンス:
-48.76%
1年 パフォーマンス:
-36.29%
1日の値動き範囲:
$1.57
$1.6986
1週間の範囲:
$1.57
$1.90
52週間の値動き範囲:
$1.45
$3.48
Heartbeam Inc Stock (BEAT) Company Profile
BEAT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.65 | 57.48M | 0 | -14.47M | -12.19M | -1.24 |
|
VEEV
Veeva Systems Inc
|
285.36 | 45.71B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
62.07 | 9.42B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
58.85 | 9.78B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
111.55 | 8.70B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
41.16 | 6.92B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-09-11 | 開始されました | Needham | Buy |
| 2020-09-02 | 開始されました | Robert W. Baird | Neutral |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2019-08-02 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | 繰り返されました | Dougherty & Company | Buy |
| 2018-07-26 | 繰り返されました | Lake Street | Buy |
| 2018-04-26 | 繰り返されました | The Benchmark Company | Buy |
| 2018-02-23 | 繰り返されました | Dougherty & Company | Buy |
| 2017-11-08 | 繰り返されました | Dougherty & Company | Buy |
| 2017-10-26 | 開始されました | Raymond James | Outperform |
| 2017-10-24 | 開始されました | SunTrust | Buy |
| 2017-08-09 | 繰り返されました | Dougherty & Company | Buy |
| 2017-07-19 | 繰り返されました | The Benchmark Company | Buy |
| 2017-04-11 | 繰り返されました | Dougherty & Company | Buy |
| 2016-12-02 | 開始されました | Dougherty & Company | Buy |
| 2016-09-13 | 開始されました | Sidoti | Buy |
| 2016-08-03 | 繰り返されました | The Benchmark Company | Buy |
| 2015-07-28 | 繰り返されました | Dougherty & Company | Buy |
| 2013-10-24 | 開始されました | The Benchmark Company | Buy |
| 2013-08-21 | 開始されました | Dougherty & Company | Buy |
すべてを表示
Heartbeam Inc (BEAT) 最新ニュース
HeartBeam CEO Named to Company’s Board of Directors - Medical Product Outsourcing
Benchmark maintains $8 target on Heartbeam stock post-1Q report - Investing.com Australia
Benchmark maintains $8 target on Heartbeam stock post-1Q report By Investing.com - Investing.com India
HeartBeam’s Positive Earnings Call Reflects Growth Potential - TipRanks
HeartBeam, Inc. (NASDAQ:BEAT) Q1 2025 Earnings Call Transcript - Insider Monkey
HeartBeam (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update - Barchart.com
HeartBeam (BEAT) Reports Advancements in Q1 2025 | BEAT Stock Ne - GuruFocus
HeartBeam reports net loss of USD 5.5M in Q1 2025 - Medical Buyer
HeartBeam, Inc. Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: HeartBeam Q1 2025 miss doesn’t deter investors By Investing.com - Investing.com South Africa
Heartbeam Inc reports results for the quarter ended March 31Earnings Summary - TradingView
HeartBeam Q1 2025 slides: FDA progress and commercial readiness amid continued losses - Investing.com Nigeria
HeartBeam, Inc. SEC 10-Q Report - TradingView
HeartBeam Reports First Quarter 2025 Results - Business Wire
The Week in Canadian Press Releases: 10 Stories You Need to See - The Globe and Mail
HeartBeam strengthens IP with US patents for cardiac monitoring - Yahoo Finance
Two New U.S. Patents Bring Total to 20 Issued Worldwide, - openPR.com
Two New U.S. Patents Bring Total to 20 Issued Worldwide, Cementing Company Leadership in Cardiac Monitoring Innovation for 12-Lead ECG Synthesis Technology: HeartBeam, Inc. (Nasdaq: BEAT) - Barchart.com
HeartBeam Secures 2 New U.S. Patents - Medical Product Outsourcing
HeartBeam (NASDAQ: BEAT) Adds Two U.S. Patents to Bolster Cardiac Monitoring IP Portfolio - Barchart.com
HeartBeam (BEAT) Expands IP Portfolio with New U.S. Patents | BEAT Stock News - GuruFocus
HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio - Business Wire
HeartBeam Expands Board with CEO Robert Eno’s Appointment - citybuzz -
HeartBeam (NASDAQ: BEAT) Appoints CEO Robert Eno To Board Of Directors - Barchart.com
HeartBeam (BEAT) Welcomes CEO Robert Eno to Its Board of Directo - GuruFocus
HeartBeam Appoints CEO Robert Eno to Board - TipRanks
HeartBeam expands board, appoints CEO to director role By Investing.com - Investing.com India
HeartBeam expands board, appoints CEO to director role - Investing.com Australia
HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth - Bluefield Daily Telegraph
HeartBeam, Inc. Appoints Robert Eno to Board of Directors - marketscreener.com
HeartBeam (NASDAQ: BEAT) Prices $10 Million Public Offering At $1.70 Per Share - Barchart.com
HeartBeam (NASDAQ: BEAT) to Report Q1 2025 Results and Provide Business Update on May 13 - Barchart.com
HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time - Bluefield Daily Telegraph
HeartBeam’s ECG technology shows promise in study for arrhythmia diagnosis - Yahoo Finance
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology - BioSpace
Strategic Collaboration with AccurKardia for Ambulatory ECG - openPR.com
Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care: HeartBeam, Inc. (Nasdaq: BEAT) - The Globe and Mail
Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care: HeartBeam, Inc. (Nasdaq: BEAT) | FinancialContent - FinancialContent
HeartBeam (NASDAQ: BEAT) Reports Positive VALID-ECG Study Results Supporting 12-Lead ECG Tech - Barchart.com
HeartBeam’s VALID-ECG Study of 12-Lead ECG Synthesis Tech Meets Endpoints - Medical Product Outsourcing
HeartBeam (BEAT) Achieves Key Milestones with Synthesized 12-Lea - GuruFocus
HeartBeam’s ECG software shows promise in clinical study - Investing.com
HeartBeam’s ECG software shows promise in clinical study By Investing.com - Investing.com India
HeartBeam announces VALID-ECG pivotal study met primary endpoint - TipRanks
Heartbeam Inc (BEAT) 財務データ
収益
当期純利益
現金流量
EPS
0.51%
0.80%
大文字化:
|
ボリューム (24 時間):